Author(s):
Nidhi Ingle, Pranali Sawant, Akshada Shinde, Ankita Belawale, Avinash A. Gunjal, Rajnikant T. Kakade
Email(s):
avinashgunjal4247@gmail.com
DOI:
10.52711/2349-2988.2025.00031 
Address:
Nidhi Ingle1, Pranali Sawant1, Akshada Shinde1, Ankita Belawale1, Avinash A. Gunjal2*, Rajnikant T. Kakade3
1Research Scholar, Siddhi’s Institute of Pharmacy, Nandgaon, Murbad, Thane, Maharashtra, India.
2Assist. Professor, Dept. of Pharmacology, Siddhi’s Institute of Pharmacy, Nandgaon, Murbad, Thane, Maharashtra, India.
3Professor, Department of Pharmaceutical Chemistry, Siddhi’s Institute of Pharmacy, Nandgaon, Murbad, Thane, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 17,
Issue - 3,
Year - 2025
ABSTRACT:
Preformulation is a group of studies that focus on the physicochemical properties of a new drug candidate that could affect the drug's functionality and the creation of dosage forms. This can provide vital information for formulation design or bolster the need for molecular modification. The intrinsic chemical and physical properties of each medication were considered prior to developing a pharmaceutical formulation. This feature provides the framework for mixing pharmaceutical ingredients with drugs to produce dosage forms. Preformulation studies explore the physicochemical properties of new drug candidates to guide dosage form design. They provide a foundation for stable, safe, and effective pharmaceutical formulations by assessing solubility, partition coefficient, polymorphism, and compatibility with excipients. This is achieved by determining the kinetic rate profiles, physical characteristics, and compatibility with other constituents of the innovative therapeutic molecules. These preformulation parameters, including polymorphic behavior of both crystalline and amorphous forms, play a crucial role in determining the drug's chemical, physical, and therapeutic properties, ultimately influencing formulation development and clinical performance.
Cite this article:
Nidhi Ingle, Pranali Sawant, Akshada Shinde, Ankita Belawale, Avinash A. Gunjal, Rajnikant T. Kakade. A Comprehensive Review on Formulation and Development of Pharmaceutical Products. Research Journal of Science and Technology. 2025; 17(3):225-0. doi: 10.52711/2349-2988.2025.00031
Cite(Electronic):
Nidhi Ingle, Pranali Sawant, Akshada Shinde, Ankita Belawale, Avinash A. Gunjal, Rajnikant T. Kakade. A Comprehensive Review on Formulation and Development of Pharmaceutical Products. Research Journal of Science and Technology. 2025; 17(3):225-0. doi: 10.52711/2349-2988.2025.00031 Available on: https://rjstonline.com/AbstractView.aspx?PID=2025-17-3-5
REFERENCES:
1. Chaurasia G. A review on pharmaceutical formulation studies in formulation and development of new drug molecules. Int J Pharm Sci Res. 2016; 7(6): 2313-2320.
2. Butler JM, Dressman JB, Amaral ME, et al. The Developability Classification System: Application of Biopharmaceutics Concept to Formulation Development. J Pharm Sci. 2016; 99(12): 4940-4954.
3. Ravi Kumar, Swati Patil, MB Patil, Mahesh S Paschapur, Sachin R Patil. Formulation and Evaluation of Captopril Fast Dissolving Tablets by WOW Tab and Effervescent Technologies. Research J. Science and Tech. 2009; 1(1): 29-32
4. V.V. Nageswara Rao, K.V. Ramana Murthy. Formulation and Evaluation of Modified Pulsincap Technique for Oral Controlled Release of Glipizide. Research J. Science and Tech. 2012; 4(1): 9-12.
5. Deepak Patel, Sunil Kumar Shah, Chandra Kishore Tyagi. Design, Formulation and Characterization of Microspheres containing Mesalamine for the Treatment of Ulcerative Colitis. Research Journal of Science and Technology. 2021; 13(3):165-9.
6. Kapil Rana, Pushpendra Sharma. Analytical Method Development and Validation for the Simultaneous Estimation of Metformin Hydrochloride and Alogliptin by RP-HPLC in Bulk and Tablet Dosage Forms. Research Journal of Science and Technology. 2021; 13(2):111-8.
7. Salminen WF, McDuffie JE, White TE, et al. Streamlining nonclinical drug development using the FDA 505(b)(2) NDA regulatory pathway. J Pharm Sci. 2018; 10(9): 2212-2215.
8. Jameel F, Hershenson S. Formulation and process development strategies for manufacturing biopharmaceuticals. Hoboken, NJ: John Wiley & Sons. 2010: 2581-9429.
9. Jansche G, Cunningham S, Derouin K, et al. Biopharmaceutical processing: development, design, and implementation of manufacturing process. Amsterdam: Elsevier. 2018; 7(6): 2313-2320.
10. O’Connor T, Lee S. Emerging technology for modernizing pharmaceutical production: continuous manufacturing. In: Developing Solid and Oral Dosage Forms. 2nd ed. Amsterdam: Elsevier. 2017. 1031-1046.
11. S. D. Mankar, Anjali Dama, M. S. Bhosale, S. S. Sidhheshwar. Design, Development, Characterization of Solid Lipid Nanoparticles for Oral Administration. Research J. Science and Tech. 2020; 12(1):79-95.
12. S. D. Mankar, Anjali Dama, M. S. Bhosale, S. S. Sidhheshwar. Design, Development, Characterization of Solid Lipid Nanoparticles for Oral Administration. Research J. Science and Tech. 2020; 12(1):79-95.
13. Rowland M, Note CR. Impact of the pharmaceutical sciences on health care: a reflection over the past 50 years. J Pharm Sci. 2012; 101(11): 4075-4099.
14. Krylova OV, Litvinova TM. History of the paste-based drug formulation development. J Pharm Sci Res. 2018; 10(9): 2212-2215.
15. Dhananjay R. Chavhan, Kaveri K. Chaudhari. Development and assessment of antifungal and antibacterial Herbal Tablets using Trachyspermum ammi. Research Journal of Science and Technology. 2025; 17(2): 162-6.
16. Harsh H. Ladm, Ashvinkumar V. Dudhrejiya. Stability Indicating Method for Simultaneously Estimation of Teneligliptin, Pioglitazone and Metformin Hydrochloride in Combined Tablet Dosage form by RP-HPLC. Research Journal of Science and Technology. 2025; 17(2):101-8.
17. Shaikh AC, Shaikh SS, Shaikh AM, Gaikwad MS, Shinde PB. Review – Formulation Development Studies. Int J Creat Res Thoughts. 2022; 10(3); 2320-2882.
18. Akash Shelke, Someshwar Mankar, Mahesh Kolhe. A Review on Analytical Methods for estimation of Apremelast in Bulk, Pharmaceutical Formulation and in Biological Samples. Research Journal of Science and Technology. 2021; 13(2): 142-6.
19. Jadhav AB, Khamkar SP. Review on Formulation Development of Diclofenac Sodium. Int J Res Publ Rev. 2023; 4(3): 2043-2047.
20. Anuja Uddhav Deokar, Suhas Siddheshwar, Sudarshan. B. Kakad. Analytical Method Development and Validation of Rivaroxaban- A Review. Research J. Science and Tech. 2020; 12(1):36-46.
21. Chaurasia G. A review on pharmaceutical preformulation studies in formulation and development of new drug molecules. Int J Pharm Sci Res. 2016; 7(6): 2313-2320.
22. Kumar V, Bala R, Gill NS. A Comprehensive Review on Tablet Coating. J Pharm Sci Res. 2019; 11(6): 2148-2153.
23. Surve AD, Kaware AS, Chaudhari AS, Rajguru AG, Dwivedi AK. Review on Capsule Filling Machines. Int J Adv Res Sci Commun Technol. 2023; 3(2): 2581-9429.
24. Vishakha Shingote, S. D. Mankar, S. B. Dighe. A Review Article on Analytical Methods Development and Validation. Research Journal of Science and Technology. 2022; 14(1):77-3.
25. Raosaheb AP, Vinayak TG, Anil PG, Dattatray PV, Vilas CA. Review on Preformulation Studies. Int J Creat Res Thoughts. 2020; 11(9); 2320-2882.